A phase IIIB, randomized, trial of open-label non-nucleoside reverse transcriptase inhibitor (NNRTI) or protease inhibitor (PI) with another PI in combination with double-blind comparison of two nucleoside reverse transcriptase inhibitors (NRTI) or a different NRTI in antiretroviral-naive subjects

Trial Profile

A phase IIIB, randomized, trial of open-label non-nucleoside reverse transcriptase inhibitor (NNRTI) or protease inhibitor (PI) with another PI in combination with double-blind comparison of two nucleoside reverse transcriptase inhibitors (NRTI) or a different NRTI in antiretroviral-naive subjects

Recruiting
Phase of Trial: Phase III

Latest Information Update: 31 Oct 2006

At a glance

  • Drugs HIV protease inhibitors; Non-nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top